A Clinical Evaluation of Dual Antiplatelet Therapy Duration Following Treatment With the Medtronic Endeavor Zotarolimus-eluting Coronary Stent.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 21 Jan 2012
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms SEASIDE
- 21 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 01 Sep 2009 New trial record